Hostname: page-component-6bb9c88b65-vqtzn Total loading time: 0 Render date: 2025-07-24T22:51:27.416Z Has data issue: false hasContentIssue false
  • English
  • Français

Antipsychotic prescribing in light of the consensus statement of the College

Published online by Cambridge University Press:  02 January 2018

K. L. Newton ,
R. Murthy  and
J. Qureshi
K. L. Newton*
Affiliation:
South Kensington and Chelsea Mental Health Centre, 1 Nightingale Place, London, SW10 9NG
R. Murthy
Affiliation:
New Cross Hospital Wolverhampton WV10 0QP
J. Qureshi
Affiliation:
New Cross Hospital Wolverhampton WV10 0QP
*
∗Correspondence
Rights & Permissions [Opens in a new window]

Abstract

Core share and HTML view are not available for this content. However, as you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

A retrospective survey was undertaken to evaluate the prescribing practices of medical staff in a District General Hospital in light of the Consensus Statement by the Royal College of Psychiatrists on the use of high dose antipsychotics (1993). Two per cent of 247 patients were prescribed a higher than recommended dose of antipsychotic. None of these cases had been prescribed ‘supra-BNF doses of antipsychotic on a regular basis, but with the addition of ‘as required’ (PRN) medication the recommended dose was exceeded. In only one patient was the high dosage administered. A further analysis of these patients is made.

Information

Type
Original Papers
Information
Psychiatric Bulletin , Volume 21 , Issue 7 , July 1997 , pp. 408 - 410
Creative Commons
Creative Common License - CCCreative Common License - BY
This is an Open Access article, distributed under the terms of the Creative Commons Attribution (CC-BY) license (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited.
Copyright
Copyright © 1997 The Royal College of Psychiatrists

References

Baldessarini, R. J., Cohen, B. M. & Tricher, M. H. (1988) Significance of neuroleptic dose and plasma level in the pharmacological treatment of psychoses. Archives of General Psychiatry, 45, 79–89.CrossRefGoogle ScholarPubMed
Bjorndal, E., Bjeere, M., Gerlach, J., et al (1980) High dose haloperidol therapy in chronic schizophrenic patients. A double blind study of clinical response, side-effects, serum haloperidol and serum prolactin. Psychopharmacology, 67, 17–23.CrossRefGoogle Scholar
Farde, L., Nondstron, A. L., Wiesel, F. A., et al (1992) Positron emmision tomographic analysis of central D1 and D2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine. Archives of General Psychiatry, 49, 538–544.CrossRefGoogle Scholar
Kane, J. M. (1987) Treatment of schizophrenia. Schizophrenia Bulletin, 13, 133–156.Google Scholar
Krasucki, C. & McFarlane, F. (1996) Electrocardiograms, high-dose antipsychotic treatment and College guidelines. Psychiatric Bulletin, 20, 326–330.Google Scholar
Royal College of Psychiatrists (1993) Consensus Statement on the Use of High Dose Antipsychotic MedicationS. London: RCPsych.Google Scholar
Warner, J. P., Slade, R. & Barnes, T. R. E. (1995) Change in neuroleptic prescribing practice. Psychiatric Bulletin, 19, 237–239.Google Scholar
Wolkin, A., Barouche, F., Wolfe, A. P., et al (1989) Dopamine receptor blockade and clinical response; evidence for two biological subgroups of schizophrenia. American Journal of Psychiatry, 146, 905–908.Google Scholar
Prescribing for unlicensed drugs or using drugs for unlicensed indications. Drug and Therapeutics Bulletin (1992) 30, 97–99.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.